Status: Not yet recruiting
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.
Participants needed: 1,200
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: The First People's Hospital of ChangzhouUpdated: Jul 1, 2015
Eligibility criteria
Histologically proven renal cell carcinoma [+5]
Patients with a history of any other neoplastic disease less than 5 years ago (e... [+7]